Key Takeaways

  • Psychedelics like psilocybin and LSD reliably induce experiences of awe, dissolving the sense of self.
  • These experiences can offer therapeutic benefits for conditions like death anxiety, addiction, and PTSD when used with proper guidance.
  • Strict cultural containers and medical supervision are essential due to the power and risks of these compounds.
  • Casual microdosing lacks scientific evidence for mental health benefits, especially compared to guided therapeutic sessions.

Beyond the Hype: Psychedelics for Awe and Healing

Andrew Huberman and Dr. Dacher Keltner explore how classic psychedelics create experiences of awe. They agree these substances open the mind. People using them often feel a dissolved sense of self, connecting instead to vast systems and shared humanity. Keltner states, “They open up your mind and you see all life forms and time is different and your sense of self vanishes… and you’re just connected to vast things, ecosystems and sense of humanity.”

This connection can be a powerful tool. The discussion points to promising applications for severe conditions. Death anxiety, addiction, and post-traumatic stress disorder (PTSD) are areas where psychedelics show therapeutic promise. The experience of awe, they suggest, lies at the heart of these potential benefits.

The Critical Container and Cautions

Despite the promise, both Huberman and Keltner urge extreme caution. Huberman specifically warns that people with a family history of psychosis or bipolar conditions “really really need to be careful.” The power of these compounds means they are not to be taken lightly. Keltner stresses the importance of respecting indigenous traditions.

He argues psychedelics demand a cultural container of inquiry and guidance. This means structured environments and trained support are not optional. The therapeutic value is tied to this careful, intentional approach, not casual use.

Microdosing: The False Promise

This is where Keltner delivers his strongest warning. He worries about the casual adoption of microdosing. “I worry about micro doing you know I think people are taking um these things like coffee and it’s not coffee.” This casual approach trivializes powerful substances.

Huberman backs this concern with current scientific data. He cites Robin Carhart-Harris, a leading researcher in the field. Carhart-Harris’s findings indicate “there’s no uh evidence of benefit from micro doing at least on major depression as compared to like two rounds of psilocybin with a guide therapy before during and after.” For ambitious builders seeking an edge, this distinction is critical. Pursuing a ‘hack’ that lacks scientific proof is a a distraction, not a shortcut.

What to Do With This

Do not waste resources or attention on microdosing for mood or focus. If you are struggling with mental health, seek interventions with strong scientific backing. Instead of casual experimentation, direct your energy toward proven methods like consistent sleep, regular exercise, or professional cognitive behavioral therapy. This week, pick one scientifically validated habit you know you should implement and commit to it daily.